Cell Growth & Differentiation, Vol 5, Issue 1 87-93, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner

LM Nabell, RH Raja, PP Sayeski, AJ Paterson and JE Kudlow
Department of Medicine, University of Alabama at Birmingham 35294.

The human immunodeficiency virus 1 (HIV-1) tat gene encodes a protein of critical importance for viral transcription. In addition, Tat has been shown capable of entering cells, stimulating cell proliferation, and altering host cell gene expression. We examined the effect of Tat on the expression of the transforming growth factor alpha (TGF-alpha) gene in MDA468 human breast carcinoma cells. We showed that these cells were capable of supporting the activation of the HIV-1 long terminal repeat by Tat. Then, in cotransfection assays, in which the TGF-alpha promoter was linked to a luciferase reporter gene and the tat gene was expressed under the control of the SV40 early promoter, we showed that tat gene expression increased TGF-alpha-luciferase reporter function but only in cells stimulated with epidermal growth factor (EGF). The effects of tat and EGF were dose dependent. To confirm these cotransfection data, Tat was expressed in Escherichia coli as a fusion protein with glutathione-S-transferase (GST) and purified on glutathione-agarose. GST-Tat was introduced into the MDA468 cells either in the presence of chloroquine or by scrape loading. The biological activity of GST-Tat was tested on cells that had been stablely transfected with the HIV-1 long terminal repeat linked to luciferase as a reporter. GST-Tat was then introduced into the cells, and the level of TGF-alpha mRNA was determined.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Rusnati, G. Tulipano, C. Urbinati, E. Tanghetti, R. Giuliani, M. Giacca, M. Ciomei, A. Corallini, and M. Presta The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists J. Biol. Chem., June 26, 1998; 273(26): 16027 - 16037. [Abstract] [Full Text] [PDF]

				M. Kundu, S. Sharma, A. De Luca, A. Giordano, J. Rappaport, K. Khalili, and S. Amini HIV-1 Tat Elongates the G1 Phase and Indirectly Promotes HIV-1 Gene Expression in Cells of Glial Origin J. Biol. Chem., April 3, 1998; 273(14): 8130 - 8136. [Abstract] [Full Text] [PDF]

				W. Xie, A. J. Paterson, E. Chin, L. M. Nabell, and J. E. Kudlow Targeted Expression of a Dominant Negative Epidermal Growth Factor Receptor in the Mammary Gland of Transgenic Mice Inhibits Pubertal Mammary Duct Development Mol. Endocrinol., November 1, 1997; 11(12): 1766 - 1781. [Abstract] [Full Text]

				M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'A. di Fagagna, M. Giacca, and M. Presta Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE J. Biol. Chem., April 25, 1997; 272(17): 11313 - 11320. [Abstract] [Full Text] [PDF]

				P. P. Sayeski and J. E. Kudlow Glucose Metabolism to Glucosamine Is Necessary for Glucose Stimulation of Transforming Growth Factor-alpha Gene Transcription J. Biol. Chem., June 21, 1996; 271(25): 15237 - 15243. [Abstract] [Full Text] [PDF]

				M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., January 26, 2001; 276(5): 3254 - 3261. [Abstract] [Full Text] [PDF]